Key facts
- This page summarizes Kamran Cheema's Form 3 filing for Akoustis Technologies, Inc..
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2024, 17:30.
Kamran Cheema - 08 Aug 2024 Form 3 Insider Report for Akoustis Technologies, Inc.
- Reporting relationship
- Interim CEO
- Issuer ticker
- N/A
- Reported as of
- 08 Aug 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Kamran Cheema, by Coleman Wombwell, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Kamran Cheema filed Form 3 for Akoustis Technologies, Inc. on 19 Aug 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AKTS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 128,011
- Date
- 08 Aug 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AKTS
holding
Derivative
Stock Options (Right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $10.02
- Footnotes
- F1
AKTS
holding
Derivative
Stock Options (Right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $8.09
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These Stock Options vest in seven equal annual installments beginning on September 8, 2022.
Footnote F2
These Stock Options vest in seven equal annual installments beginning on November 9, 2022.